This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2014 Oct 4;384(9950):1260-1.

doi: 10.1016/S0140-6736(14)61761-X.

Neuraminidase inhibitors for influenza complications

Chris Del Mar¹, Peter Doshi², Rokuro Hama³, Mark Jones⁴, Tom Jefferson⁵, Carl Heneghan⁶, Igho Onakpoya⁶, Jeremy Howick⁶

Affiliations

Affiliations

¹ Centre for Research in Evidence Based Practice, Bond University, Robina, QLD 4226, Australia. Electronic address: cdelmar@bond.edu.au.
² University of Maryland School of Pharmacy, MD, USA.
³ Japan Institute of Pharmacovigilance, Osaka, Japan.
⁴ School of population health, University of Queensland, QLD, Australia.
⁵ Cochrane Collaboration, Rome, Italy.
⁶ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

PMID: 25283565
DOI: 10.1016/S0140-6736(14)61761-X

Comment

Neuraminidase inhibitors for influenza complications

Chris Del Mar et al. Lancet. 2014.

. 2014 Oct 4;384(9950):1260-1.

doi: 10.1016/S0140-6736(14)61761-X.

Authors

Chris Del Mar¹, Peter Doshi², Rokuro Hama³, Mark Jones⁴, Tom Jefferson⁵, Carl Heneghan⁶, Igho Onakpoya⁶, Jeremy Howick⁶

Affiliations

¹ Centre for Research in Evidence Based Practice, Bond University, Robina, QLD 4226, Australia. Electronic address: cdelmar@bond.edu.au.
² University of Maryland School of Pharmacy, MD, USA.
³ Japan Institute of Pharmacovigilance, Osaka, Japan.
⁴ School of population health, University of Queensland, QLD, Australia.
⁵ Cochrane Collaboration, Rome, Italy.
⁶ Nuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.

PMID: 25283565
DOI: 10.1016/S0140-6736(14)61761-X

No abstract available

PubMed Disclaimer

Comment in

Neuraminidase inhibitors for influenza complications--Authors' reply.
Nguyen-Van-Tam JS, Openshaw PJ, Nicholson KG. Nguyen-Van-Tam JS, et al. Lancet. 2014 Oct 4;384(9950):1261-2. doi: 10.1016/S0140-6736(14)61762-1. Lancet. 2014. PMID: 25283566 No abstract available.

Comment on

Antivirals for influenza: where now for clinical practice and pandemic preparedness?
Nguyen-Van-Tam JS, Openshaw PJ, Nicholson KG. Nguyen-Van-Tam JS, et al. Lancet. 2014 Aug 2;384(9941):386-7. doi: 10.1016/S0140-6736(14)60726-1. Epub 2014 May 14. Lancet. 2014. PMID: 24837882 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions

Substances

Actions
Actions

Grants and funding

10/80/01/DH_/Department of Health/United Kingdom

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
- scite Smart Citations
Medical
- MedlinePlus Health Information